Lv613
2204 积分 2022-12-12 加入
Oncology Meets Immunology: The Cancer-Immunity Cycle
17天前
已完结
Physical training and exercise in myasthenia gravis
19天前
已完结
A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapies
24天前
已完结
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
24天前
已完结
Efficacy and Safety of BL-B01D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Phase II Clinical Trial
24天前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
24天前
已完结
Down syndrome and Alzheimer's disease: insights into biomarkers, clinical symptoms, and pathology
24天前
已完结
Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease
24天前
已完结
High burdens of phosphorylated tau protein and distinct precuneus atrophy in sporadic early-onset Alzheimer’s disease
24天前
已完结
Antibody-drug conjugates (ADCs): “smart missiles” targeting cancer therapy
1个月前
已完结
皖公网安备34019202002308
